Discovery of new muscarinic acetylcholine receptor antagonists from Scopolia tangutica
Open Access
- 7 April 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 7 (1), srep46067
- https://doi.org/10.1038/srep46067
Abstract
Scopolia tangutica (S. tangutica) is a traditional Chinese medicinal plant used for antispasmodics, anesthesia, analgesia and sedation. Its pharmacological activities are mostly associated with the antagonistic activity at muscarinic acetylcholine receptors (mAchRs) of several known alkaloids such as atropine and scopolamine. With our recent identification of four hydroxycinnamic acid amides from S. tangutica, we hypothesized that this plant may contain previously unidentified alkaloids that may also contribute to its in vivo effect. Herein, we used a bioassay-guided multi-dimension separation strategy to discover novel mAchR antagonists from S. tangutica. The core of this approach is to use label-free cell phenotypic assay to first identify active fractions, and then to guide purification of active ligands. Besides four tropanes and six cinnamic acid amides that have been previously isolated from S. tangutica, we recently identified two new tropanes, one new cinnamic acid amide, and nine other compounds. Six tropane compounds purified from S. tangutica for the first time were confirmed to be competitive antagonists of muscarinic receptor 3 (M3), including the two new ones 8 and 12 with IC50 values of 1.97 μM and 4.47 μM, respectively. Furthermore, the cinnamic acid amide 17 displayed 15-fold selectivity for M1 over M3 receptors. These findings will be useful in designing lead compounds for mAchRs and elucidating mechanisms of action of S. tangutica.Keywords
This publication has 48 references indexed in Scilit:
- Development and validation of a rapid and sensitive assay for the determination of anisodamine in 50 μL of beagle dog plasma by LC-MS/MSJournal of Separation Science, 2013
- Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor familyBMC Pharmacology and Toxicology, 2013
- A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case studyBMC Pharmacology and Toxicology, 2013
- High levels of jasmonic acid antagonize the biosynthesis of gibberellins and inhibit the growth of Nicotiana attenuata stemsThe Plant Journal, 2012
- Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) AgonistsACS Medicinal Chemistry Letters, 2012
- Discovery of 2-(4-Methylfuran-2(5H)-ylidene)malononitrile and Thieno[3,2-b]thiophene-2-carboxylic Acid Derivatives as G Protein-Coupled Receptor 35 (GPR35) AgonistsJournal of Medicinal Chemistry, 2011
- Label-free integrative pharmacology on-target of drugs at the β2-adrenergic receptorScientific Reports, 2011
- Interplay between NS3 protease and human La protein regulates translation-replication switch of Hepatitis C virusScientific Reports, 2011
- Effect of the vapour phase on the TLC separation of tropane alkaloidsActa Chromatographica, 2010
- Kinetic Study of Littorine Rearrangement inDaturainnoxiaHairy Roots by13C NMR SpectroscopyJournal of Natural Products, 2002